ACCELERATING YOUR PRODUCTS
We believe the future of precision-based medicine lies in collaboration. We're committed to partnering with clinicians, researchers, and industry leaders to advance precision diagnostics.
Let’s work together to transform patient care. Explore our full suite of solutions.
Our expert-driven, innovative discovery approach—spans research and bioinformatics to clinical product launch via our CLIA-certified lab, and custom production workflows. And it’s all accomplished within a quality-focused, regulatory-aligned environment.
- Tumor-Only. Tumor-Normal and Germline Exomes
- Whole Transcriptome. Targeted RNASeq and ncRNAs
- Functional Binding Multicell Assay
- Exome Analysis Options: SNVs, indels, CNVs, Structural Varients, HLA, Tumor Mutational Burden, Homologous Recombination Deficiency, Annotated VCF
-
RNA Pipeline: Differential Expression, Fusion Detection, Variant Calling, Splice Variants
- Multiomic Signature Discovery, TCR Clonotype Antigen Indentification, Custom Pipeline Building and Predictive Modeling
- Simulate 100s of Drug Combinations against Multiomic Personalized Tumor Models
Coming soon!
Contact us to learn more by clicking here. [Routes to contact us page]
Note from Verici content: “Proteomics should have a graphic of icons that represent NGS, bioinformatics, proteomics see below”